ARTICLE | Finance
Tending the stable
HBM BioVentures holding off on new investments, focusing on existing portfolio
June 11, 2012 7:00 AM UTC
HBM BioVentures (SIX:HBMN) won't be making new investments this fiscal year, CEO Andreas Wicki told BioCentury. Indeed, the firm's last new investment was in June 2011.
Instead, the firm will tend to its portfolio of 25 private and public companies. "We are focusing on our winners, making sure that our most promising companies are fed well," Wicki said...